EUDA Health Holdings Limited — Form 6-K Summary
Business Context and Reporting Period
EUDA Health Holdings Limited, a foreign private issuer filing on Form 20-F, furnished this Form 6-K dated January 17, 2024, for the month of January 2024. The filing reports developments concerning the continued Nasdaq Capital Market listing of the Company’s securities.
Key Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics.
Material Changes and Nasdaq Listing Status
- On January 9, 2024, Nasdaq notified the Company that its Market Value of Listed Securities had fallen below the $35 million requirement under Nasdaq Listing Rule 5550(b)(2), based on the preceding 30 consecutive business days.
- The notice did not immediately affect the listing. The Company was given until July 8, 2024, to regain compliance.
- Compliance required the Company’s Market Value of Listed Securities to close at or above $35 million for at least 10 consecutive business days during the compliance period.
- On January 16, 2024, Nasdaq notified the Company that the requirement had been satisfied for 10 consecutive business days from January 2 through January 16, 2024.
- The Company therefore regained compliance with the Nasdaq minimum market value requirement. The filing does not report any delisting action.
Outlook, Risks, and Unusual Items
If the Company had failed to regain compliance by July 8, 2024, Nasdaq could have issued a delisting notice. The Company would have had the right to appeal, but the filing stated that continued listing could not be assured. The immediate listing deficiency was resolved as of January 16, 2024.
Investor Verification Items
- Verify the Company’s current Nasdaq listing status and whether any additional continued-listing requirements or notices have arisen.
- Review the January 16, 2024 press releases furnished as Exhibits 99.1 and 99.2 for the detailed Nasdaq notices.
- Assess the potential impact of market-value volatility on future listing compliance.
- Review the Company’s latest annual and interim filings for financial performance, liquidity, capital structure, and other material risks, which are not addressed in this Form 6-K.